ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,377Medicare Part D Prescriptions Filled, Including Refills

Rank: 97 out of 4623

$983K Total Retail Price of All Prescriptions

Rank: 156 out of 4623

664 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 664 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 14,469 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 685 557 1 1
SIMVASTATIN 611 506 2 2
AMLODIPINE BESYLATE 566 462 3 5
PRAVASTATIN SODIUM 520 383 4 11
ATORVASTATIN CALCIUM 479 379 5 12
ALENDRONATE SODIUM 469 431 6 22
OMEPRAZOLE 397 294 7 7
GLIMEPIRIDE 375 309 8 38
JANUVIA 375 315 8 52
NEXIUM 355 252 10 17
METFORMIN HCL 355 273 10 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 343 249 12 19
MELOXICAM 326 277 13 27
RANITIDINE HCL 313 263 14 47
LISINOPRIL 310 257 15 4
TAMSULOSIN HCL 305 263 16 29
GLYBURIDE-METFORMIN HCL 301 254 R 17 56
DIOVAN HCT 279 222 18 67
FUROSEMIDE 256 218 19 8
METFORMIN HCL ER 242 191 20 51
METOPROLOL TARTRATE 239 193 21 9
IBUPROFEN 217 136 22 65
HYDROCHLOROTHIAZIDE 216 190 23 10
DOXAZOSIN MESYLATE 211 172 24 98
SERTRALINE HCL 204 165 25 26
CILOSTAZOL 203 158 26 176
LOSARTAN POTASSIUM 195 174 27 21
CAPTOPRIL 193 170 28 215
LOVASTATIN 191 166 29 34
LOSARTAN-HYDROCHLOROTHIAZIDE 189 144 30 46
ZOLPIDEM TARTRATE 180 126 31 18
FINASTERIDE 173 140 32 109
METOPROLOL SUCCINATE 173 162 32 13
ACARBOSE 167 129 34 329
CLOPIDOGREL 165 145 35 31
ENALAPRIL MALEATE 160 142 36 41
ATENOLOL 149 101 37 28
ISOSORBIDE MONONITRATE ER 146 128 38 60
HYDROCODONE-ACETAMINOPHEN 139 33 S3 39 3
TRAMADOL HCL 134 45 40 15
DIOVAN 132 117 41 39
LIPITOR 126 90 42 100
TRAZODONE HCL 125 121 43 42
POTASSIUM CHLORIDE 124 104 44 14
CIPROFLOXACIN HCL 122 95 45 43
DONEPEZIL HCL 111 103 46 30
NIFEDIPINE ER 110 85 47 97
CARVEDILOL 104 91 48 25
LANTUS 100 91 49 44
GABAPENTIN 100 37 49 16
PLAVIX 99 88 51 45
NAPROXEN 99 63 51 63
INSULIN SYRINGE 98 76 53 85
TRAMADOL HCL-ACETAMINOPHEN 96 81 54 103
GEMFIBROZIL 95 70 55 94
NOVOLOG MIX 70-30 93 64 56 200
LABETALOL HCL 93 70 56 226
DIGOXIN 91 78 58 58
MIRTAZAPINE 90 86 59 57
CITALOPRAM HBR 87 57 60 23
PANTOPRAZOLE SODIUM 85 75 61 35
ENALAPRIL-HYDROCHLOROTHIAZIDE 84 74 62 292
NAMENDA 77 77 63 36
WARFARIN SODIUM 75 52 64 24
GENERLAC 74 52 65 240
SINGULAIR 74 57 65 83
AMITRIPTYLINE HCL 69 54 R 67 69
PROAIR HFA 68 49 68 64
ACTOS 68 58 68 87
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 48 70 68
SPIRONOLACTONE 65 49 70 77
NOVOLOG 63 57 72 123
FLUTICASONE PROPIONATE 62 43 73 32
NOVOLIN R 61 55 74 113
PHENYTOIN SODIUM EXTENDED 59 28 75 119
HYDRALAZINE HCL 59 51 75 99
MONTELUKAST SODIUM 58 44 77 158
ESCITALOPRAM OXALATE 56 42 78 75
SUCRALFATE 56 26 78 183
CLOTRIMAZOLE-BETAMETHASONE 55 42 80 147
MICARDIS HCT 54 54 81 430
ALLOPURINOL 52 51 82 37
NOVOLOG MIX 70-30 FLEXPEN 52 40 82 223
HUMALOG MIX 75-25 51 35 84 307
VALSARTAN-HYDROCHLOROTHIAZIDE 50 40 85 351
METHOTREXATE 50 31 85 289
LYRICA 50 34 85 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.